Eli Lilly and Company has broken ground on a new $5-billion manufacturing facility in Goochland County, Virginia, west of Richmond, Virginia, which will produce active pharmaceutical ingredients (APIs ...

The deeper threat to the biopharmaceutical industry may come not from macro-level disruption, but from structural pressures ...

How AI and other digital tools are progressing across the bio/pharmaceutical industry is on top of mind. Key perspectives on ...

Merck KGaA has agreed to acquire Silence Therapeutics, a Cambridge, UK-based clinical-stage bio/pharmaceutical company developing short interfering RNA (siRNA) medicines, for $1.3 billion, ...

Sanofi has broken ground on a new insulin manufacturing facility in Frankfurt, Germany. The new facility will be built on a 36,000-square-meter footprint at the Sanofi BioCampus in Frankfurt.

The Board of Directors of CSL, a Melbourne, Australia-based bio/pharmaceutical company, has appointed Deborah Waterhouse, currently Chief Executive Officer (CEO) of ViiV Healthcare, a joint venture ...

What are key trends for injectable drugs and the related market impact? From switches from IV-administered to subcutaneous drug delivery and increased interest for home and self administration, DCAT ...

US CEOs are confident in their AI progress and the strength of the US economy, but cybersecurity and geopolitical risks are intensifying while inflation pressures persist, according to a new study by ...

The continued ascent of biologics in the industry’s pipeline and in commercial products bodes well for CDMOs of biologics, but how is the industry trending overall in terms of biomanufacturing ...

BD (Becton, Dickinson and Company), a medical technology company, has announced a partnership with the US government under which the company has agreed to invest $19 billion in the US over several ...